Sirexatamab(TD-HF914016) is a research-grade recombinant antibody targetingDickkopf-1. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.
Species reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species
Humanized
Isotype
IgG4-kappa
Clonality
Monoclonal
Target
Dickkopf-1, SK, hDkk-1, Dkk-1, Dickkopf-related protein 1, DKK1
Endotoxin level
Please contact the lab for this information.
Purity
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
O94907
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names
DKN-01, LY-28121762414962-49-3
Background
Sirexatamab is an active peptide. Sirexatamab can be used for various biochemical studies.
Caption
SEC-HPLC detection for Research Grade Sirexatamab. | SDS-PAGE for Research Grade Sirexatamab.
Note
For research use only. Not suitable for clinical or therapeutic use.